Robert A Rieger

Title: Innovations of Robert A. Rieger

Introduction

Robert A. Rieger is an accomplished inventor based in Boulder, Colorado. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds for FGFR inhibition. His work is crucial in advancing treatments for various diseases.

Latest Patents

Robert A. Rieger holds 1 patent for his invention titled "Compounds for FGFR inhibition." This patent describes a compound with a specific structure, including stereoisomers, salts, or tautomers. The pharmaceutical composition comprising these compounds and their applications in treating diseases are also detailed in the patent.

Career Highlights

Rieger is currently associated with Cogent Biosciences, Inc., where he continues to innovate in the pharmaceutical sector. His expertise in FGFR inhibition has positioned him as a key player in the development of new therapeutic strategies.

Collaborations

Throughout his career, Robert has collaborated with notable professionals, including Jay Bradford Fell and John E. Robinson. These partnerships have enhanced his research and contributed to the success of his projects.

Conclusion

Robert A. Rieger's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions to FGFR inhibition are paving the way for new treatment options, showcasing the importance of research and collaboration in advancing healthcare solutions.